Key participants in GERD Drugs and Devices market include Johnson & Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Merck & CO., Inc., Boston Scientific Corporation, Eisai Co., Ltd., and Ironwood Pharmaceuticals, Inc., among others.

Vancouver, British Columbia, April 28, 2021 (GLOBE NEWSWIRE) -- The global GERD Drugs and Devices market is forecasted to be worth USD 6.14 Billion by 2027, according to a current analysis by Emergen Research. The market is being driven by the growth in the number of unmet medical needs. The increased prevalence of the disease in world populations, limited treatment options, the need for new approve medical regulations, and growth in the geriatric population will drive the market demand.

Certain factors such as stress, consumption of fast food, and intake of aerated and alcohol drinks have led to the rise in prevalence of GERD globally. A growing number of companies across the globe, coupled with a shift in government focus on the promotion of consumer accessibility, will further drug price reduction, which will fuel the market demand.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/383

The lack of new regulatory approved medication, as well as limited acceptability of devices, are the major limitations of the market. The rise in demand for acid-reducing drugs due to the increased incidence of heartburn will boost the demand for GERD Drugs and Devices Market. The growing trend of self-medication and raising awareness about the disease will create a demand for drugs and devices.

Key Highlights From The Report

• In October 2020, Dr. Reddy launched a generic product in the United States to treat gastroesophageal reflux disease. Famotidine tablets are used to relieve and prevent heartburn related to acid indigestion and sour stomach brought on by the consumption of certain food and beverages.
• Proton Pump Inhibitor (PPIs) are used for the treatment of ulcers in the stomach, and the part of the gut called the duodenum. These drugs are used to reduce acid reflux, which may lead to inflammation or heartburn of oesophagitis. Some of the PPIs are lansoprazole, esomeprazole, omeprazole, rabeprazole, and pantoprazole.
• The LINX Management System is a fundic-sparing anti-reflux, a laparoscopic procedure indicated for patients diagnosed with Gastroesophageal Reflux Disease. As the LINX procedure takes less than an hour, and most patients are able to resume a normal diet immediately.
• The Asia Pacific region is expected to grow due to the rise in the older population and change in the dietary and lifestyle risk factors such as high-fat diet and obesity, respectively. In developing nations such as China and India, the trend of self-treatment is surging rapidly, and the affordability and availability of OTC drugs will fuel the market growth.
• Key participants include Johnson & Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Merck & CO., Inc., Boston Scientific Corporation, Eisai Co., Ltd., and Ironwood Pharmaceuticals, Inc., among others.

Check Our Prices@ https://www.emergenresearch.com/select-license/383
For the purpose of this report, Emergen Research has segmented into the global GERD Drugs and Devices Market on the basis of route of administration, drug type, device type, and region:

• Route Of Administration Outlook (Revenue, USD Billion; 2017-2027)
  • Oral
  • Parenteral
• Drug Type Outlook (Revenue, USD Billion; 2017-2027)
  • H2 Receptor Antagonist
  • Proton Pump Inhibitor (PPIs)
  • Antacids
• Device Type Outlook (Revenue, USD Billion; 2017-2027)
  • MUSE –Medigus Ultrasonic Surgical Endostapler
  • LINX Management System
  • Stretta Therapy
  • Bravo Reflux Testing System
  • Digitrapper reflux testing system
  • Others

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:   https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market

• Regional Outlook (Revenue, USD Billion; 2017-2027)
  • North America
    1. U.S.
    2. Canada
  • Europe
    1. Germany
    2. UK
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • MEA
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

Take a Look at our Related Reports:

Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions

Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-gerd-drugs-and-devices-market